Status:

UNKNOWN

Multiple Nutritional Deficiencies Causing Dementia of the Alzheimer Type

Lead Sponsor:

Oslo University Hospital

Collaborating Sponsors:

South Eastern Area Health Service

Conditions:

Mild Cognitive Impairment

Alzheimers Disease

Eligibility:

All Genders

Brief Summary

The purpose of the study is to compare the concentrations of Vitamin B1 (thiamine), Vitamin B6 (pyridoxal-5-phosphate), folate, Vitamin B12 (cobalamin), Vitamin C (ascorbic acid), Vitamin A (retinol),...

Detailed Description

Dementia of the Alzheimer type (AD) is a serious illness affecting 60-70 000 people in Norway with an estimated cost of 12 Billion NOK (Norwegian kroner) per year. The Department of Social Affairs and...

Eligibility Criteria

Inclusion

  • Cognitive impairment with a MMSE score of 24 or better.
  • Depression score below 9 both on MADRS and Cornell.

Exclusion

  • Acute or chronic disease with CRP above 10.
  • Lewy Body Dementia or Frontal Lobe Dementia.
  • Dementia due to a known brain vascular disturbance, hemorrhage or thrombosis.
  • Patients who had not stopped their intake of vitamins and food additives the last four weeks.

Key Trial Info

Start Date :

January 1 2012

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2013

Estimated Enrollment :

180 Patients enrolled

Trial Details

Trial ID

NCT01479855

Start Date

January 1 2012

End Date

December 1 2013

Last Update

November 27 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

OsloUH, Ullevål

Oslo, Norway, 0424